IL2RG and severe combined immunodeficiency: This established cytokine dose and combination were then further validated in 8-week-old to 10-week-old nonobese diabetic/severe combined immunodeficiency interleukin 2 receptor gamma chain null (NOD/SCID-IL2Rγ−/−; NSG) mice.